A clinical trial underway in South Africa and Uganda has shown that a twice-yearly injection of a new PrEP drug gives young women total protection from HIV infection, according to a July 10 report at ScienceAlert.com, republished from The Conversion. The trial was designed to test whether a six-month injection of lenacapavir provides better protection […]
